Search Results for 'Palbociclib Fulvestrant'

Palbociclib Fulvestrant published presentations and documents on DocSlides.

Her-2 negative MBC

conchita-marotz
47 Slides

10/25/2016. Objectives. General principles. Endoc...

Hormone Receptor-Positive Advanced Breast Cancer:

min-jolicoeur
0 Slides

HR Advanced Breast Cancer:. Introduction. Case S...

The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer

min-jolicoeur
0 Slides

HR Advanced Breast Cancer. Introduction. Restagi...

BELLE-3: A Phase III Study of

faustina-dinatale
0 Slides

Buparlisib. and . Fulvestrant. in Postmenopausa...

Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer

min-jolicoeur
0 Slides

This program will include a discussion of off-lab...

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

olivia-moreira
67 Slides

Jointly provided by ...

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

min-jolicoeur
22 Slides

CDK 4/6 Inhibitors in Breast Cance...

Targeting endocrine-resistance pathways in breast cancer

alexa-scheidler
48 Slides

Targeting endocrine-resistance pathways in breas...

Hormone Receptor Positive Metastatic Breast Cancer

pamella-moone
80 Slides

. 5/9/2017. The Lancet July 11, 1895. ON THE TRE...

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

calandra-battersby
74 Slides

An Interactive Oncology Grand Rounds Series. Joyc...

PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo

tawny-fly
7 Slides

Post-Menopausal Women with Hormone-Receptor Posit...

Endocrine resistance: molecular pathways and rational development of targeted therapies

spottletoefacebook
66 Slides

Grazia Arpino. Università di Napoli Federico II. ...

CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing

leah
28 Slides

Mansoor A Khan, BS, MS, BCOP. Oncology/Hematology/...

Fulvestrant 500 mg versus

elena
30 Slides

anastrozole. as first-line treatment for advanced...

Supplementary Material and Figures

SoulfulDreamer
8 Slides

Analysis . of the CDK4/6 Cell-Cycle Pathway in Lei...

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor

byrne
18 Slides

Overall survival and updated progression-free surv...

Module 8: ER-Positive Metastatic

anastasia
50 Slides

Breast Cancer . Elizabeth O’Reilly, MSN, MPH, AN...

Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in m

felicity
1 Slides

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor...